Patent ID: 11894121
Assignee: REVIV GLOBAL LTD
Field: Medical technology (Instruments)
Classification: CPC G | IPC G

Claim 13:
14. A method of creating a genetically personalized intravenous or intramuscular nutrition therapy treatment formula, the method comprising:
(a) receiving medical information, genetic information, and therapeutic objectives of a patient as inputs for a personalized nutrition therapy formula creation algorithm, wherein the genetic information comprises genetic test results and the medical information comprises at least one of blood test results, vital signs, medical histories, medical diagnoses, current symptoms, diseases of which the patient is at heightened risk, and family history;
(b) creating a custom intravenous or intramuscular nutrition therapy treatment formula from the personalized nutrition therapy formula creation algorithm based on the medical information, genetic information, and therapeutic objectives that is personalized to the patient, wherein ingredients of the custom intravenous or intramuscular nutrition therapy treatment formula comprise one or more micronutrients identified by the personalized nutrition therapy formula creation algorithm as a match for the medical information, genetic information, and therapeutic objectives of the patient based on individual scores stored in the database of a plurality of existing individual scientific literature references relating to the one or more micronutrients and individual treatment scores stored in the database of previous intravenous or intramuscular nutrition therapy treatments comprising the one or more micronutrients, wherein the individual scores and the individual treatment scores are specific to the medical information, genetic information, and therapeutic objectives, and wherein the personalized nutrition therapy formula creation algorithm identifies a micronutrient as a match for the medical information, genetic information, and therapeutic objectives when the individual scores and the individual treatment scores add up to a predetermined threshold;
(c) treating the patient with the custom intravenous or intramuscular nutrition therapy treatment formula;
(d) receiving feedback data about an effectiveness of treating the patient with the custom intravenous or intramuscular nutrition therapy treatment formula, wherein the feedback data comprises feedback about at least one of measured bloodwork, epigenetic changes, improvements or declines in symptoms, progress towards reaching therapeutic objectives, vital signs, overall health and fitness, and physical or mental energy;
(e) assigning an individual treatment score for treatment of the patient with the custom intravenous or intramuscular nutrition therapy treatment formula based on the feedback data, and entering the individual treatment score electronically into a computer system associated with the database so that the individual treatment score is stored in the database, wherein a value of the individual treatment score is weighted based on one or more factors, wherein the individual treatment score is positive when the feedback data shows improvement of the medical information or the therapeutic objectives of the patient, and wherein the individual treatment score is negative when the feedback data shows worsening of the medical information or the therapeutic objectives of the patient;
(f) updating the personalized nutrition therapy formula creation algorithm to incorporate the individual treatment score for the custom intravenous or intramuscular nutrition therapy treatment formula on the patient;
(g) using the updated personalized nutrition therapy formula creation algorithm for treating subsequent patients by creating future custom intravenous or intramuscular nutrition therapy treatment formulas based on the updated personalized nutrition therapy formula creation algorithm, wherein the updated personalized nutrition therapy formula creation algorithm is configured to create custom intravenous or intramuscular nutrition therapy treatment formulas for each subsequent individual patient that comprise micronutrients that most closely match the subsequent individual patient needs based on available patient medical information, genetic information, and therapeutic objectives, and most current aggregated feedback based on real patients with similar genes and symptoms; and
(h) repeating steps (a)-(g) for subsequent patients to create a feedback loop of automatically applying patient therapy feedback data to the personalized nutrition therapy formula creation algorithm so that new custom intravenous or intramuscular nutrition therapy treatment formulas are created based on the feedback data received from previous patients who received custom intravenous or intramuscular nutrition therapy treatment formulas through the personalized nutrition therapy formula creation algorithm,
wherein at least some of the patient and the subsequent patients are positioned geographically remotely from each other.